Actively Recruiting

Phase Not Applicable
Age: 18Years - 60Years
All Genders
NCT06362382

Mobile Internet-based Remote Home Rehabilitation Improves Prognostic Function and Life Quality in Pulmonary Hypertension

Led by China-Japan Friendship Hospital · Updated on 2025-02-10

80

Participants Needed

1

Research Sites

105 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The goal of this clinical trial is to learn the effectiveness of remote home-based exercise rehabilitation using mobile Internet technology for patients with pulmonary hypertension,especically providing early and mid-term results of its effectiveness. The main questions it aims to answer are: Dose tele-rehabilitation training improves prognostic function and quality of life in patients with pulmonary hypertension? Researchers will compare tele-rehabilitation training group to a control group (receive health propaganda and education, and then follow their daily routine after discharge from the hospital) to see if tele-rehabilitation training works to improve prognosis. Participants will: During their stay in the hospital, the patients of tele-rehabilitation training group were accompanied by a rehabilitation trainer and a psychotherapist for a complete cycle of (7 days ± 3 days 1 week/times) standardized training. The scheme of rehabilitation is impedance training. A specialized professional team including cardiologists, rehabilitation trainers, psychotherapists and radiologists were involved. After discharge from the hospital, patients in the rehabilitation group underwent 3-5 weekly daily training sessions and intensive supervision and management by the online community at least once a week. Visit the clinic at the 3rd month of the study. Extended follow-up up to 6 months may be considered if patients are cooperative and could complete the training program in the first 3 months.

CONDITIONS

Official Title

Mobile Internet-based Remote Home Rehabilitation Improves Prognostic Function and Life Quality in Pulmonary Hypertension

Who Can Participate

Age: 18Years - 60Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 to 60 years old
  • Pulmonary hypertension defined by mean pulmonary artery pressure > 20 mmHg, pulmonary artery wedge pressure ≤ 15 mmHg, and pulmonary vascular resistance > 2 Wood units measured by right heart catheterization at rest
  • Diagnosis of arterial pulmonary hypertension, pulmonary hypertension associated with lung disease, or chronic thromboembolic pulmonary hypertension (CTEPH) according to WHO classification
  • No fainting or near-fainting episodes during walking or recovery
  • No serious arrhythmia caused by rest or exercise such as ventricular tachycardia, ventricular fibrillation, or Class III atrioventricular block
  • Stable medication regimen for at least 3 months prior to randomization and no organized exercise training for at least 3 months prior to screening
  • Proficient in using smartphones and monitoring devices
  • Signed informed consent form
Not Eligible

You will not qualify if you...

  • History of venous thromboembolism (VTE)
  • Acute pulmonary embolism
  • Low-intensity exercise (<3 METs) or symptoms/signs of angina pectoris during recovery
  • Hemodynamic abnormalities during exercise such as systolic blood pressure not rising or falling, or arrhythmia when exercise load increases
  • Severe psycho-cognitive disorders
  • Neurological or musculoskeletal dysfunction preventing exercise
  • Patients with CTEPH scheduled for percutaneous pulmonary artery balloon dilation or pulmonary artery endarterectomy within 6 months
  • Combination of other serious underlying diseases such as malignant tumors, pulmonary tuberculosis, hyperthyroidism, or severe depression
  • Pregnancy
  • Refusal to sign informed consent form

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Fuwai Hospital

Beijing, Beijing Municipality, China, 100037

Actively Recruiting

Loading map...

Research Team

X

Xiaoming Zhou, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here